BOCA RATON, Fla., Sept. 15 /PRNewswire/ -- Watermark Medical, Inc., a privately-held, medical products and services company servicing the sleep-disordered breathing market, has expanded the market reach of its Web-enabled in-home sleep apnea testing device through strategic alliances with three leading sleep solution providers in the U.S. and Canada. The new partners are SleepQuest, a national provider of comprehensive sleep apnea services; Sleep Optima, which provides sleep apnea services through a growing network of dentists; and The Snore Shop, which offers sleep apnea services. Based on Watermark Medical's expertise and credibility in the in-home testing market, these companies chose to use the Watermark ARES™ in three distinct types of practice settings, demonstrating the versatility of the Watermark device.
Watermark ARES™ (Apnea Risk Evaluation System) is the first FDA-cleared, CMS approved, in-home, wire-free, ambulatory sleep test device that provides physicians with a highly accurate, lower-cost tool to diagnose patients who may be suffering from Obstructive Sleep Apnea (OSA). The ARES™ integrates physiological data acquired in-home with clinical history and anthropomorphic data to determine the presence and severity of OSA.
"Through these partnerships, Watermark is making Web-enabled in-home testing and diagnosis even more accessible to the millions of Americans suffering from sleep apnea," said Charlie Alvarez, co-founder and president of Watermark Medical. "The ARES device saves patients significant time and money, but can also save lives. Accurate and timely diagnosis of sleep apnea is critical because sleep apnea is linked to chronic health conditions such as obesity, heart disease, diabetes and hypertension."